MARY AUSTIN: Open Payments
NPI 1437854643 · BOONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,718 in 88 payments from 18 companies in 2025. Trend: 2023 $773 · 2024 $916 · 2025 $1,718
Food & beverage: $1,718
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $266 |
| Axsome Therapeutics, Inc. | 13 | $254 |
| E.R. Squibb & Sons, L.L.C. | 4 | $220 |
| Collegium Pharmaceutical, Inc. | 12 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $177 |
| ACADIA Pharmaceuticals Inc | 2 | $99 |
| Teva Pharmaceuticals USA, Inc. | 5 | $84 |
| Alkermes, Inc. | 4 | $72 |
| Janssen Pharmaceuticals, Inc | 3 | $68 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
Products named: VRAYLAR, Auvelity, COBENFY, Jornay PM, CAPLYTA, NUPLAZID, AUSTEDO XR, ARISTADA.
Industry payments across IN — which companies pay providers there.
